These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 16508900)

  • 1. Cortical microcircuits in schizophrenia--the dopamine hypothesis revisited.
    Winterer G
    Pharmacopsychiatry; 2006 Feb; 39 Suppl 1():S68-71. PubMed ID: 16508900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genes, dopamine and cortical signal-to-noise ratio in schizophrenia.
    Winterer G; Weinberger DR
    Trends Neurosci; 2004 Nov; 27(11):683-90. PubMed ID: 15474169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Deficit schizophrenia: from pharmacology to clinical practice].
    Tassin JP
    Encephale; 1996 Jun; 22 Spec No 2():9-12. PubMed ID: 8767035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toward a prefrontal microcircuit model for cognitive deficits in schizophrenia.
    Wang XJ
    Pharmacopsychiatry; 2006 Feb; 39 Suppl 1():S80-7. PubMed ID: 16508903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopaminergic control of working memory and its relevance to schizophrenia: a circuit dynamics perspective.
    Tanaka S
    Neuroscience; 2006 Apr; 139(1):153-71. PubMed ID: 16324800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine modulation of prefrontal cortex interneurons occurs independently of DARPP-32.
    Trantham-Davidson H; Kröner S; Seamans JK
    Cereb Cortex; 2008 Apr; 18(4):951-8. PubMed ID: 17693396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative analysis of the expression of dopamine D1 and D2 receptors in pyramidal and GABAergic neurons of the rat prefrontal cortex.
    Santana N; Mengod G; Artigas F
    Cereb Cortex; 2009 Apr; 19(4):849-60. PubMed ID: 18689859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET.
    Okubo Y; Suhara T; Suzuki K; Kobayashi K; Inoue O; Terasaki O; Someya Y; Sassa T; Sudo Y; Matsushima E; Iyo M; Tateno Y; Toru M
    Nature; 1997 Feb; 385(6617):634-6. PubMed ID: 9024661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine and serotonin interactions in the prefrontal cortex: insights on antipsychotic drugs and their mechanism of action.
    Di Pietro NC; Seamans JK
    Pharmacopsychiatry; 2007 Dec; 40 Suppl 1():S27-33. PubMed ID: 18080940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional and anatomical aspects of prefrontal pathology in schizophrenia.
    Goldman-Rakic PS; Selemon LD
    Schizophr Bull; 1997; 23(3):437-58. PubMed ID: 9327508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deciphering the disease process of schizophrenia: the contribution of cortical GABA neurons.
    Lewis DA; Hashimoto T
    Int Rev Neurobiol; 2007; 78():109-31. PubMed ID: 17349859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. D2-like but not D1-like dopamine receptors are involved in the ventrolateral orbital cortex-induced antinociception: a GABAergic modulation mechanism.
    Sheng HY; Qu CL; Huo FQ; Du JQ; Tang JS
    Exp Neurol; 2009 Jan; 215(1):128-34. PubMed ID: 18952080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Distribution and function of dopamine D1, D2 receptor].
    Suhara T; Miyoshi M
    Rinsho Shinkeigaku; 2007 Nov; 47(11):826-8. PubMed ID: 18210808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prefrontal cortex-nucleus accumbens interaction: in vivo modulation by dopamine and glutamate in the prefrontal cortex.
    Del Arco A; Mora F
    Pharmacol Biochem Behav; 2008 Aug; 90(2):226-35. PubMed ID: 18508116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of cortical inhibition in the pathophysiology and treatment of schizophrenia.
    Daskalakis ZJ; Fitzgerald PB; Christensen BK
    Brain Res Rev; 2007 Dec; 56(2):427-42. PubMed ID: 17980435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [GABA-B-associated neuropsychiatric disorders].
    Eichhammer P; Langguth B; Zowe M; Kleinjung T; Jacob P; Sand P; Hajak G
    Psychiatr Prax; 2004 Nov; 31 Suppl 1():S44-6. PubMed ID: 15570498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal effective connectivity of dopamine D2 receptor binding in schizophrenia.
    Yasuno F; Suhara T; Okubo Y; Ichimiya T; Takano A; Sudo Y; Inoue M
    Psychiatry Res; 2005 Apr; 138(3):197-207. PubMed ID: 15854788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do we still believe in the dopamine hypothesis? New data bring new evidence.
    Abi-Dargham A
    Int J Neuropsychopharmacol; 2004 Mar; 7 Suppl 1():S1-5. PubMed ID: 14972078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A dynamical model of event-related FMRI signals in prefrontal cortex: predictions for schizophrenia.
    Deco G
    Pharmacopsychiatry; 2006 Feb; 39 Suppl 1():S65-7. PubMed ID: 16508899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The complexity of the dopaminergic synapses and their modulation by antipsychotics.
    Leuner K; Müller WE
    Pharmacopsychiatry; 2006 Feb; 39 Suppl 1():S15-20. PubMed ID: 16508891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.